Thursday, November 29, 2012
Protein tyrosine phosphatase 1B (PTP-1B; PTPN1)
Cell culture and feline
studies suggest PTP-1B inhibitors could increase the efficacy of interferon
therapies against viral infections. In cultured cells infected with HCV or
vesicular stomatitis virus, type 1 interferon (IFN1)
plus the PTP-1B inhibitor 7-CBNP decreased viral replication
compared with IFN1 alone. In cats with chronic infection of feline
calicivirus, submucosal injection of 7-CBNP decreased inflammation compared
with that seen prior to treatment. Next steps include using 7-CBNP or other
PTP-1B inhibitors in nonmouse models of viral infection, including HIV-related
feline immunodeficiency virus (FIV).
TransTech Pharma Inc.'s PTP-1B
is in Phase II testing to treat diabetes.
Isis Pharmaceuticals Inc.'s ISIS-PTP1bRx,
a PTP-1B antisense oligonucleotide, is in Phase I testing to treat diabetes.
Ohr Pharmaceutical Inc.'s trodusquemine
a small molecule PTP-1B inhibitor, is in Phase I testing for the same
SciBX 5(46); doi:10.1038/scibx.2012.1210
Published online Nov. 29, 2012
Patented; available for
Carbone, C.J. et al.
Proc. Natl. Acad. Sci. USA; published online Nov. 5, 2012;
Contact: Serge Y. Fuchs, University of Pennsylvania, Philadelphia,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]